Articles

RiverTown Therapeutics Inc. Clinical Update

September 14, 2017 /

I’ve had many readers inquire lately about the current progress of RiverTown Therapeutics Inc.’s RT1640. RTI’s therapy for hair regeneration, RT1640, is a topical medication composed of minoxidil, cyclosporine A, and a novel molecule called RT175. The company debuted some impressive hair growth photos on this site last year. The question that’s been on a…

Asia: Hair Growth R&D

July 6, 2017 /

Just when we thought we knew of every company in the world working on hair growth treatments… With all of the scientific articles on hair biology that continually get published from Asian establishments there was bound to be a few companies springing up at some point. I’m happy to say I’ve got 4 new companies…

2017: A Look Ahead

January 11, 2017 /

I’ve got a good feeling about 2017… For the past several years we have been pacified by the news of a research study or startup company working on a treatment that grows hair. Ultimately, we would prefer the treatment in our hands, but reading about it on a computer screen has been supportive as well.…

Kelopesia Update, Brotzu Trial, Cures: Weekly Thoughts 12/16/16

December 16, 2016 /

Hey everybody, welcome to another edition of Weekly Thoughts. This week I touch on two topicals that have been at the forefront of hair growth enthusiasts’ attention this past year. Also, I take a look at an intriguing healthcare legislation that was just passed this week in the United States. Kelopesia Update Remember when Kelopesia…

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.